Clinical trials
Suspended Leukemia, Myeloid, Acute trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 5 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Suspended | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| City of Hope Medical Center | 6 |
| National Cancer Institute (NCI) | 2 |
| Curis, Inc. | 1 |
| David Wald | 1 |
| Fred Hutchinson Cancer Center | 1 |
| Huda Salman | 1 |
| Leland Metheny | 1 |
| University of Chicago | 1 |
| University of Maryland, Baltimore | 1 |
| Washington University School of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 16 |
| Myelodysplastic Syndromes | 8 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 |
| Hematologic Neoplasms | 2 |
| Hodgkin Disease | 2 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 |
| Colorectal Neoplasms | 1 |
| Enteropathy-Associated T-Cell Lymphoma | 1 |
| Esophageal Neoplasms | 1 |
| GATA2 Deficiency | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.